Low LDL Target, No Clinical Gain in Non-CAD Diabetes: EMPATHY

Statins aimed at reducing LDL-C to less than 70 mg/dL didn't cut cardiovascular events, but an intriguing post hoc finding suggests there may yet be benefit, in this trial of patients with diabetic retinopathy.
Medscape Medical News

Full Story →